JP Morgan 2025: Dexcom shares up 5% after 2025 outlook forecasts $4.6bn in revenue
Buoyed by the recent launch of Stelo and further upcoming CGM launches, Dexcom is anticipating a 14% growth in 2025 over 2024.
Buoyed by the recent launch of Stelo and further upcoming CGM launches, Dexcom is anticipating a 14% growth in 2025 over 2024.
Analysis by GlobalData has identified that innovative cardiovascular devices are driving diversification in the growing market.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Medical Technology is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Smartwatch app could help people quit smoking
Capstan Medical secures $110m for robotic-assisted heart valve implants
‘Major milestone’ for UK clinical trials as new framework laid in parliament
EndoQuest wins FDA IDE to commence robot trial in colorectal indication